Cited by 2Potassium and Related DisordersAdrenal Hormones and DisordersElectrolyte and hormonal disorders

Hypokalemic paralysis in an adolescent following dexamethasone and B12 injection: A case report and literature review

Open access
Sahebi, Keivan, Foroozand, Hassan, Bahmei, Mohammad, Taghizadeh, Raziee, Zare, Samane, Inaloo, Soroor·2025·Heliyon

Abstract

The widespread use of glucocorticoids in clinical practice may occasionally be complicated by hypokalemic paralysis. Previously, only a few cases of glucocorticoid-induced hypokalemic paralysis in healthy adults had been reported. Intriguingly, cases of B12-induced hypokalemia have previously been reported in patients with pernicious anemia. Recently, we experienced a case of hypokalemic paralysis in an adolescent following intramuscular injections of dexamethasone and vitamin B12. Upon exclusion of other causes, a presumptive diagnosis of glucocorticoid-induced hypokalemic paralysis, with a possible but uncertain contribution from B12 supplementation, was made for the patient. After potassium replacement therapy, the patient fully recovered and was discharged after five days. Although glucocorticoids are known to cause hypokalemia through mechanisms such as enhanced transcellular shift or renal excretion, the potential role of vitamin B12 in worsening this effect remains unclear. It is hypothesized that B12 supplementation under certain conditions could influence electrolyte balance and potentially amplify the hypokalemic effects of glucocorticoids. However, this hypothesis is based on a few cases, and further pathophysiological and clinical studies are needed to clarify whether B12 supplementation exacerbates hypokalemia induced by glucocorticoids or if the observation is coincidental or context-specific. Meanwhile, clinicians should be cautious when prescribing glucocorticoids, particularly in combination with B12 supplements. This includes ensuring that both are administered only when clinically indicated, monitoring vital signs and serum potassium levels in at-risk patients, and considering alternatives when appropriate.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.heliyon.2025.e41675

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Corticosteroids enhance Na+/K+-ATPase activity both directly and indirectly by altering glucose metabolism.

    “Corticosteroids enhance Na+/K+-ATPase activity both directly and indirectly by altering glucose metabolism.”

    From Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms (2025) · cites this paper as [38]

    The Introduction and Discussion say glucocorticoids may activate Na+/K+-ATPase and that glucocorticoid-induced hyperglycemia can lead to hyperinsulinemia and a shift of potassium into cells. They do not say corticosteroids directly activate the pump or that the glucose-mediated pathway increases pump activity; the Introduction instead describes pump activation as possibly indirect. No page numbers are available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Corticosteroids stimulate hepatic gluconeogenesis and may upregulate insulin secretion, thereby further promoting intracellular potassium uptake.

    “Sahebi et al. [38] and Mebane et al. [42] reported that corticosteroids stimulate hepatic gluconeogenesis and may upregulate insulin secretion, thereby further promoting intracellular potassium uptake.”

    From Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms (2025) · cites this paper as [38]

    The Introduction and Discussion (pages not provided) say glucocorticoid-induced hyperglycemia can lead to compensatory hyperinsulinemia, which shifts potassium into cells. They do not attribute the hyperglycemia to stimulation of hepatic gluconeogenesis, so that specific mechanism is unsupported by this source. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sahebi, K., Foroozand, H., Bahmei, M., Taghizadeh, R., Zare, S., & Inaloo, S.
Affiliations
Shiraz University (IR)
Corresponding author
  • Foroozand, Hassan
  • Inaloo, Soroor
Venue
Heliyon
Publisher
Elsevier BV
Published
2025-01
Volume
11
Issue
2
Pages
e41675
ISSN
2405-8440 (ISSN-L)
OpenAlex
W4406205298
Cited by
2
References
41
Citations by year
2026: 1 · 2025: 1
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Heliyon (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Potassium and Related Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
Keywords
hypokalemic paralysis, dexamethasone, vitamin B12 supplementation, potassium replacement therapy, adolescents, drug-induced hypokalemia, electrolyte imbalance, glucocorticoid adverse effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review